Gemmus Pharma
San Francisco · Founded 2007
About Gemmus Pharma
Gemmus Pharma is a drug development company founded in 2007 to commercialize in-licensed technology from a major pharmaceutical company. Gemmus' lead candidate is a cardiovascular drug currently marketed in Asia that has been repurposed for use as a treatment for influenza. Gemmus has received support from the National Institute of Allergy and Infectious Disease (NIAID) and has completed a Series A round. Gemmus plans to file an investigational new drug (IND) application with the FDA for treatment of influenza infections in 2014.
Company Facts
- Founded: 2007
- Legal name: Gemmus Pharma Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.1M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2014)
- Website: gemmuspharma.com
- Phone: 4159781908
Canonical: https://fsome.com/organization/gemmus-pharma-8256709 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.